First Time Loading...

Shanghai Haohai Biological Technology Co Ltd
SSE:688366

Watchlist Manager
Shanghai Haohai Biological Technology Co Ltd Logo
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Watchlist
Price: 97.34 CNY 1.19% Market Closed
Updated: May 9, 2024

Wall Street
Price Targets

Price Targets Summary
Shanghai Haohai Biological Technology Co Ltd

Wall Street analysts forecast Shanghai Haohai Biological Technology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Haohai Biological Technology Co Ltd is 130.05 CNY with a low forecast of 116.15 CNY and a high forecast of 147 CNY.

Lowest
Price Target
116.15 CNY
19% Upside
Average
Price Target
130.05 CNY
34% Upside
Highest
Price Target
147 CNY
51% Upside
Shanghai Haohai Biological Technology Co Ltd Competitors:
Price Targets
BIOG B
Biogaia AB
27% Upside
9969
InnoCare Pharma Ltd
59% Upside
BIO
Biotest AG
19% Downside
688319
Chengdu Olymvax Biopharmaceuticals Inc
158% Upside
4891
TMS Co Ltd
208% Upside
DNLI
Denali Therapeutics Inc
120% Upside
CDMO
Avid Bioservices Inc
54% Upside
APGE
Apogee Therapeutics Inc
67% Upside

Revenue
Forecast

Revenue Estimate
Shanghai Haohai Biological Technology Co Ltd

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 17%.

12%
Past Growth
17%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Shanghai Haohai Biological Technology Co Ltd

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's operating income is 1%. The projected CAGR for the next 2 years is 26%.

1%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Shanghai Haohai Biological Technology Co Ltd

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 15%.

2%
Past Growth
15%
Estimated Growth
Estimates Accuracy
15%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Haohai Biological Technology Co Ltd's stock price target?
Price Target
130.05 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai Haohai Biological Technology Co Ltd is 130.05 CNY with a low forecast of 116.15 CNY and a high forecast of 147 CNY.

What is Shanghai Haohai Biological Technology Co Ltd's Revenue forecast?
Projected CAGR
17%

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 17%.

What is Shanghai Haohai Biological Technology Co Ltd's Operating Income forecast?
Projected CAGR
26%

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's operating income is 1%. The projected CAGR for the next 2 years is 26%.

What is Shanghai Haohai Biological Technology Co Ltd's Net Income forecast?
Projected CAGR
15%

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 15%.